Ginkgo Bioworks is a Massachusetts-based horizontal platform that offers solutions including cell programming and therapeutics discovery for the pharmaceutical sector.
Business Model:
Revenue: $359.5M
Employees: 501-1,000
Address: 27 Drydock Avenue
City: Boston
State: MA
Zip: 02210
Country: US
Ginkgo Bioworks is a Massachusetts-based horizontal platform that offers solutions including cell programming and therapeutics discovery for the pharmaceutical sector.
Contact Phone:
+18774225362
Contact Email:
Listed Exchange:
NYSE
IPO Date:
9/17/2021
IPO Valuation:
$15B
Ticker Symbol:
DNA
Amount Raised:
$2B
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2019 | Synlogic | Equity | 80M |
9/2021 | Cambium | Seed Round | 8M |
10/2020 | Allonnia | Series A | 40M |
7/2022 | Phytolon | Series A | 14.5M |
9/2017 | Joyn Bio | Series A | 0 |
3/2018 | Joyn Bio | Series A | 0 |
10/2018 | Genomatica | Equity | 90M |
7/2022 | Phytolon | Series A | 0 |
10/2020 | Allonnia | Series A | 0 |
6/2019 | Synlogic | Post-IPO Equity | 0 |
10/2018 | Genomatica | Venture Round | 0 |
3/2018 | Joyn Bio | Series A | 0 |
9/2017 | Joyn Bio | Series A | 0 |
Announced Date | Name | Price |
---|---|---|
7/2022 | Zymergen | |
6/2022 | Bitome | |
3/2022 | FGen | |
1/2022 | Project Beacon COVID-19 | |
5/2021 | Dutch DNA | |
12/2020 | Novogy | |
5/2019 | Warp Drive Bio | |
1/2017 | Gen9 |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|